PEP-Therapy
Mario Campone is the CEO of Institut de Cancérologie de l'Ouest (ICO), a Hospital Practitioner at the ICO Department of Medical Oncology, Head of the Phase I unit certified by the National Cancer Institute and breast cancer unit. Scientific Director of Cancéropôle Grand Ouest and Professor of medical oncology at the University of Angers.
This person is not in the org chart
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.